Amitiza
NDC 64764-240, lubiprostone, capsule, gelatin coated, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 64764-240
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64764-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE24 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64764-240-60 | 64764024060 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (64764-240-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d474ac6a-444d-4aa6-9986-24be6fcf811d
Use it
Look up 64764-240 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64764-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64764-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.